Telomerase gene therapy prevents age-related lung fibrosis in mice
Pulmonary Fibrosis News - 19-Aug-2020Could pave way for preventing the disease in humans and improve healthspan
Spanish National Cancer Research Center (CNIO)
Center for cancer research, including diagnosis and treatments
The Spanish National Cancer Research Centre is a public institution of excellence committed to research, diagnosis and treatment for cancer. The CNIO currently houses 22 Research Groups, organised in 7 Scientific Programmes, plus 5 Clinical Research Unit(s) that work closely with several hospitals. These scientific groups are supported by 19 Core Units that provide state-of-the-art facilities and technical expertise. The CNIO also has an Experimental Therapeutics Programme leader in academic drug discovery.
Visit website: https://www.cnio.es/en/
Details last updated 07-Nov-2019
Spanish National Cancer Research Center (CNIO) News
A step closer to reversing pulmonary fibrosis via telomerase gene therapy
Lifespan.io (LEAF) - 12-Aug-2020Study in mice revealed great progress and potential for curing fibrotic diseases in humans
Rapamycin decreased survival and longevity in mice with short telomeres
Phys.org - 03-Mar-2020mTOR, a pro-survival pathway for shorter telomeres and inhibition is deleterious
Pluripotency and telomeres, butterfly effect discovered
ScienceDaily - 20-Aug-2019Pluripotent cells are like a black box, but they can open new doors for regenerative medicine
Reversing epigenetic changes rejuvenated mice with progeria
MIT Technology Review - 08-Aug-2019Could turning back the clock on genes make us live much longer?
Display all news
People at Spanish National Cancer Research Center (CNIO)
